It has been a bit of a sour week for drinkers of raw milk.
Yesterday, the U.S. Food and Drug Administration said a federal court had granted it a permanent injunction to keep a Pennsylvania raw milk maker from distributing across state lines to raw milk buying clubs. The decision was the latest in an escalating battle between the federal government and producers and consumers of raw milk.
Originally published on Thu February 23, 2012 10:19 am
Since we introduced you to AeroShot, a product that delivers a blast of caffeine through an inhaler, a few months back, it seems a lot of folks — mostly around college campuses in New York and Boston — have tried the quick pick-me-up.
The Supreme Court has officially declined to decide one of its bigger cases of the term: whether or not doctors, hospitals and other health care providers can sue a state to challenge cuts in the Medicaid health program for the poor.
A key federal panel Wednesday recommended the Food and Drug Administration approve the first new weight-loss drug in more than a decade.
At the conclusion of a day-long hearing, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 to endorse a request from Vivus to approve the drug Qnexa. The same panel gave a thumbs-down to Qnexa in 2010.
Qnexa is a combination of two generic drugs that are already on the market: